Biomarin Pharmaceutical Vs. Dave Industry Stock Comparison

Buy

66

BMRN
Biomarin Pharmaceutical

Last Price:

$70.79

Seasonality Move:

1.51%

Buy

76

DAVE
Dave

Last Price:

$83.34

Seasonality Move:

-3.93%

Buy

66

Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

The current Biomarin Pharmaceutical [BMRN] share price is $70.54. The Score for BMRN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

76

Dave (DAVE) is a Buy

Is Dave a Buy, Sell or Hold?

The current Dave [DAVE] share price is $86.06. The Score for DAVE is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
DAVE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

The Biomarin Pharmaceutical share price today is $70.54

The current trend is moderately bullish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

DAVE Stock Price Chart

What is Dave's stock price today?

The Dave share price today is $86.06

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAVE is experiencing slight buying pressure.

BMRN Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.76	Buy
Relative Strength Index (14 RSI):	59.31	Buy
Chaikin Money Flow:	591244	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(64.14 - 70.66)	Buy
Bollinger Bands (100):	(63.51 - 69.11)	Buy

DAVE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.67	Sell
Relative Strength Index (14 RSI):	40.93	Sell
Chaikin Money Flow:	91000	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(90.1 - 110.3)	Sell
Bollinger Bands (100):	(60.08 - 104)	Buy

BMRN Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	71.05	Sell
20-day SMA:	68.36	Buy
50-day SMA:	66	Buy
200-day SMA:	73.96	Sell
8-day EMA:	70.58	Sell
20-day EMA:	68.87	Buy
50-day EMA:	67.2	Buy
200-day EMA:	72.72	Sell

DAVE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	89.02	Sell
20-day SMA:	100.01	Sell
50-day SMA:	95.43	Sell
200-day SMA:	59.7	Buy
8-day EMA:	88.74	Sell
20-day EMA:	94.56	Sell
50-day EMA:	93.18	Sell
200-day EMA:	66.88	Buy

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.13 per share, an increase this year of $1.00 per share, and an increase next year of $1.04 per share.

Dave Earnings Growth & DAVE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.83 per share, an increase next quarter of $0.09 per share, an increase this year of $1.90 per share, and an increase next year of $0.79 per share.

Biomarin Pharmaceutical Technical Analysis

	Feb 26	Feb 27	Feb 28	Mar 3	Mar 4	Mar 5	Mar 6	Mar 7	Mar 11	Mar 12
	Feb				Mar
	26	27	28	03	04	05	06	07	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dave Technical Analysis

	Feb 26	Feb 27	Feb 28	Mar 3	Mar 4	Mar 5	Mar 6	Mar 7	Mar 11	Mar 12
	Feb				Mar
	26	27	28	03	04	05	06	07	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):